Martin Overseas

Tucatinib (150 mg) is an oral medication used in combination therapy for the treatment of certain cancers. It's a targeted therapy known as a kinase inhibitor that works by blocking the HER2 protein, which is often overexpressed in specific types of cancer, promoting their growth.UsesHER2-Positive Breast Cancer: Tucatinib is used in combination with trastuzumab and capecitabine for adults with advanced unresectable or metastatic HER2-positive breast cancer, including those with brain metastases. This is typically for patients who have already received at least one prior anti-HER2 treatment.RAS Wild-type, HER2-Positive Colorectal Cancer: It is also used with trastuzumab for adults with RAS wild-type HER2-positive unresectable or metastatic colorectal cancer that has worsened after prior chemotherapy.

GEFTILON 250MG TABLET contains Gefitinib which belongs to the group of medicines called Antineoplastics. It is indicated for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who have activating mutation of the EGFR-TK.

Axitinib is used in combination with avelumab (Bavencio) or pembrolizumab (Keytruda) to treat advanced renal cell carcinoma. Axitinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply

Folitrax 7.5 Tablet is a medicine used for treatment of cancer in various parts of the body such as breasts, head, neck, lungs, blood, bone, lymph, and uterus. It is also used to treat rheumatoid arthritis, severe and uncontrolled psoriasis, and Crohn’s disease.